Product
IMM2520
Name
IMM2520
1 clinical trial
3 drugs
6 indications
Indication
Advanced Solid TumorIndication
Lung CancerIndication
Small Cell Lung CancerIndication
Breast CancerIndication
Squamous Cell Carcinoma of Head and NeckIndication
Colorectal CancerDrug
DocetaxelDrug
SulfasalazineClinical trial
A Phase 1 Clinical Study to Evaluate IMM2520 Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-03-10